Hyperfine (HYPR) Competitors $1.27 -0.02 (-1.55%) Closing price 04:00 PM EasternExtended Trading$1.27 0.00 (0.00%) As of 04:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HYPR vs. DCTH, SNWV, BFLY, CLPT, NPCE, RXST, DRTS, CATX, TCMD, and STIMShould you be buying Hyperfine stock or one of its competitors? The main competitors of Hyperfine include Delcath Systems (DCTH), Sanuwave Health (SNWV), Butterfly Network (BFLY), ClearPoint Neuro (CLPT), NeuroPace (NPCE), RxSight (RXST), Alpha Tau Medical (DRTS), Perspective Therapeutics (CATX), Tactile Systems Technology (TCMD), and Neuronetics (STIM). These companies are all part of the "medical equipment" industry. Hyperfine vs. Its Competitors Delcath Systems Sanuwave Health Butterfly Network ClearPoint Neuro NeuroPace RxSight Alpha Tau Medical Perspective Therapeutics Tactile Systems Technology Neuronetics Delcath Systems (NASDAQ:DCTH) and Hyperfine (NASDAQ:HYPR) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, media sentiment, dividends, profitability and analyst recommendations. Which has higher earnings and valuation, DCTH or HYPR? Delcath Systems has higher revenue and earnings than Hyperfine. Hyperfine is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDelcath Systems$37.21M9.93-$26.39M$0.05211.20Hyperfine$12.89M7.67-$40.72M-$0.52-2.44 Does the media refer more to DCTH or HYPR? In the previous week, Hyperfine had 12 more articles in the media than Delcath Systems. MarketBeat recorded 18 mentions for Hyperfine and 6 mentions for Delcath Systems. Hyperfine's average media sentiment score of 0.54 beat Delcath Systems' score of -0.08 indicating that Hyperfine is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Delcath Systems 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Hyperfine 4 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders believe in DCTH or HYPR? 61.1% of Delcath Systems shares are held by institutional investors. Comparatively, 15.0% of Hyperfine shares are held by institutional investors. 17.9% of Delcath Systems shares are held by company insiders. Comparatively, 31.0% of Hyperfine shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Is DCTH or HYPR more profitable? Delcath Systems has a net margin of 3.18% compared to Hyperfine's net margin of -364.54%. Delcath Systems' return on equity of 6.91% beat Hyperfine's return on equity.Company Net Margins Return on Equity Return on Assets Delcath Systems3.18% 6.91% 5.80% Hyperfine -364.54%-84.82%-69.39% Do analysts prefer DCTH or HYPR? Delcath Systems presently has a consensus price target of $24.50, indicating a potential upside of 132.01%. Hyperfine has a consensus price target of $1.28, indicating a potential upside of 1.05%. Given Delcath Systems' stronger consensus rating and higher probable upside, research analysts clearly believe Delcath Systems is more favorable than Hyperfine.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Delcath Systems 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Hyperfine 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Which has more volatility and risk, DCTH or HYPR? Delcath Systems has a beta of 0.82, meaning that its stock price is 18% less volatile than the S&P 500. Comparatively, Hyperfine has a beta of 1.06, meaning that its stock price is 6% more volatile than the S&P 500. SummaryDelcath Systems beats Hyperfine on 12 of the 16 factors compared between the two stocks. Get Hyperfine News Delivered to You Automatically Sign up to receive the latest news and ratings for HYPR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HYPR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HYPR vs. The Competition Export to ExcelMetricHyperfineMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$98.84M$7.10B$5.76B$9.65BDividend YieldN/A1.32%3.91%4.09%P/E Ratio-2.4427.2030.7825.12Price / Sales7.67150.49456.64116.46Price / CashN/A22.1625.2228.45Price / Book1.904.789.375.95Net Income-$40.72M$178.31M$3.26B$265.46M7 Day Performance5.83%-0.74%1.88%0.96%1 Month Performance38.03%-1.19%3.73%2.47%1 Year Performance18.14%12.72%28.93%20.24% Hyperfine Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HYPRHyperfine1.5259 of 5 stars$1.27-1.6%$1.28+1.0%+21.7%$98.84M$12.89M-2.44190Earnings ReportAnalyst RevisionDCTHDelcath Systems2.638 of 5 stars$10.51+5.0%$24.50+133.1%+42.0%$350.16M$37.21M210.2060Short Interest ↑SNWVSanuwave Health2.5192 of 5 stars$42.74+7.5%$49.00+14.6%N/A$340.66M$32.63M-5.1840Positive NewsGap DownHigh Trading VolumeBFLYButterfly Network3.0434 of 5 stars$1.37+2.6%$3.00+119.8%+50.8%$334.82M$82.06M-4.88460News CoverageCLPTClearPoint Neuro1.7003 of 5 stars$10.60-2.0%$19.67+85.5%+4.4%$302.84M$31.39M-13.95110Earnings ReportNPCENeuroPace3.2721 of 5 stars$8.89-1.0%$17.00+91.2%+22.6%$294.53M$79.91M-10.58170News CoverageEarnings ReportShort Interest ↑Analyst RevisionRXSTRxSight1.5058 of 5 stars$6.65-7.5%$10.00+50.4%-83.9%$294.19M$139.93M-8.31220Trending NewsShort Interest ↑DRTSAlpha Tau Medical2.5543 of 5 stars$3.56+5.0%$8.00+124.7%+49.5%$287.54MN/A-7.7480High Trading VolumeCATXPerspective Therapeutics1.7036 of 5 stars$3.72+1.1%$12.56+237.5%-72.6%$276.13MN/A0.0070News CoverageAnalyst RevisionTCMDTactile Systems Technology2.4606 of 5 stars$12.17-0.9%$13.50+10.9%-3.2%$273.75M$292.98M19.631,037STIMNeuronetics2.3215 of 5 stars$3.92-5.1%$5.00+27.6%+216.1%$273.10M$74.89M-3.47180Positive NewsGap Up Related Companies and Tools Related Companies Delcath Systems Alternatives Sanuwave Health Alternatives Butterfly Network Alternatives ClearPoint Neuro Alternatives NeuroPace Alternatives RxSight Alternatives Alpha Tau Medical Alternatives Perspective Therapeutics Alternatives Tactile Systems Technology Alternatives Neuronetics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HYPR) was last updated on 8/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hyperfine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hyperfine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access